100 related articles for article (PubMed ID: 31929871)
21. Diagnostic delay in Parkinson's disease caused by PRKN mutations.
Ruiz-Lopez M; Freitas ME; Oliveira LM; Munhoz RP; Fox SH; Rohani M; Rogaeva E; Lang AE; Fasano A
Parkinsonism Relat Disord; 2019 Jun; 63():217-220. PubMed ID: 30692050
[TBL] [Abstract][Full Text] [Related]
22. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.
Ross OA; Haugarvoll K; Stone JT; Heckman MG; White LR; Aasly JO; Mark Gibson J; Lynch T; Wszolek ZK; Uitti RJ; Farrer MJ
Parkinsonism Relat Disord; 2007 Oct; 13(7):386-8. PubMed ID: 17400506
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.
Erer S; Egeli U; Zarifoglu M; Tezcan G; Cecener G; Tunca B; Ak S; Demirdogen E; Kenangil G; Kaleagası H; Dogu O; Saka E; Elibol B
Clin Neurol Neurosurg; 2016 Sep; 148():147-53. PubMed ID: 27455133
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Single Nucleotide Polymorphisms of
Shi CH; Cheng Y; Tang MB; Liu YT; Yang ZH; Li F; Fan Y; Yang J; Xu YM
Front Neurol; 2018; 9():387. PubMed ID: 29899728
[TBL] [Abstract][Full Text] [Related]
25. Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.
Shi C; Zheng Z; Wang Q; Wang C; Zhang D; Zhang M; Chan P; Wang X
PLoS One; 2016; 11(6):e0155758. PubMed ID: 27299523
[TBL] [Abstract][Full Text] [Related]
26. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of LRRK2 in Parkinson's disease in Han Chinese population.
Zhang JR; Jin H; Li K; Mao CJ; Yang YP; Wang F; Gu CC; Zhang HJ; Chen J; Liu CF
Neurobiol Aging; 2018 Dec; 72():187.e5-187.e10. PubMed ID: 30049590
[TBL] [Abstract][Full Text] [Related]
28. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
29. Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population.
Fang J; Yi K; Guo M; An X; Qu H; Lin Q; Bi M; Ma Q
Parkinsons Dis; 2016; 2016():3474751. PubMed ID: 27668119
[TBL] [Abstract][Full Text] [Related]
30. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.
González-Casacuberta I; Juárez-Flores DL; Ezquerra M; Fucho R; Catalán-García M; Guitart-Mampel M; Tobías E; García-Ruiz C; Fernández-Checa JC; Tolosa E; Martí MJ; Grau JM; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
Aging (Albany NY); 2019 Jun; 11(11):3750-3767. PubMed ID: 31180333
[TBL] [Abstract][Full Text] [Related]
32. Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers.
Castelo Rueda MP; Zanon A; Gilmozzi V; Lavdas AA; Raftopoulou A; Delcambre S; Del Greco M F; Klein C; Grünewald A; Pramstaller PP; Hicks AA; Pichler I
NPJ Parkinsons Dis; 2023 Apr; 9(1):65. PubMed ID: 37072441
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of PODXL gene in patients with familial and young-onset Parkinson's disease in a Taiwanese population.
Chen SJ; Wu RM; Ho CH; Cheng J; Lin HY; Lin CH
Neurobiol Aging; 2019 Dec; 84():235.e9-235.e10. PubMed ID: 31564376
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric Symptoms and Cognitive Impairment in Chinese Patients with Parkinson's Disease in Han and Hui Ethnicity.
Yao ML; Zhang H; Xu Y; Zhang SM; Gao YZ; Shu M; Zhang JJ
Curr Med Sci; 2019 Feb; 39(1):122-126. PubMed ID: 30868501
[TBL] [Abstract][Full Text] [Related]
35. The genetic landscape of Parkinson's disease.
Lunati A; Lesage S; Brice A
Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
[TBL] [Abstract][Full Text] [Related]
36. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes of Genetic Parkinson's Disease.
Aasly JO
J Mov Disord; 2020 May; 13(2):81-96. PubMed ID: 32498494
[TBL] [Abstract][Full Text] [Related]
39. [New polymorphism (IVS3-20 T-->C) of the parkin gene associated with the early-onset Parkinson's disease in Chinese].
Zou HQ; Chen B; Ma QL; Li X; Yang JF; Feng XL; Dong XM; Li YJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):219-23. PubMed ID: 15192821
[TBL] [Abstract][Full Text] [Related]
40. Genetic and Clinical Predictors of Deep Brain Stimulation in Young-Onset Parkinson's Disease.
Pal GD; Hall D; Ouyang B; Phelps J; Alcalay R; Pauciulo MW; Nichols WC; Clark L; Mejia-Santana H; Blasucci L; Goetz CG; Comella C; Colcher A; Gan-Or Z; Rouleau GA; Marder K;
Mov Disord Clin Pract; 2016; 3(5):465-471. PubMed ID: 27709117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
